Icon
+91 94997 68112
Login Register

Symtuza - (800 mg/150 mg/ 200 mg/10 mg ; Tablets)

Darunavir, Cobicistat, Emtricitabine, Tenofovir Alafenamide Janssen Pharma
800 mg/150 mg/ 200 mg/10 mg ; Tablets
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
 None
None None
SYMTUZA is a four-drug combination of darunavir (DRV), a human immunodeficiency virus (HIV-1) protease inhibitor, cobicistat (COBI), a CYP3A inhibitor, and emtricitabine (FTC) and tenofovir alafenamide (TAF), both HIV-1 nucleoside analog reverse transcriptase inhibitors, and is indicated as a complete regimen for the treatment of HIV-1 infection in adults: • who have no prior antiretroviral treatment history or • who are virologically suppressed (HIV-1 RNA less than 50 copies per mL) on a stable antiretroviral regimen for at least 6 months and have no known substitutions associated with resistance to darunavir or tenofovir.
Yes
****** ** *** ****** ****** *** ******* '*** *** '*** ** ******* *******. ***** ******* ** *** *** ****** ****** ** **** *******. **** ***** *** ****** ***** ** ************ ** ****** '***. ** ** ***'* ****** ******* ****** ** ** ****** *** **, ****.
Symtuza Patent 1 Patent 2 Patent 3 Patent 4 Patent 5 Patent 6 Patent 7 Patent 8 Patent 9 Patent 10 Patent 11 Patent 12 Patent 13
***** ******* *** ********* *** ********* *** ********* *** ********* *** ********* ******* ******* ****** ************/ ******** ********* ******* ****** ************/ ******** ********* ******* ****** ******** ****** ****** ******** ****** *** *********
****** *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* ******* ******* ******* ****** *** ****** ******** ****** ****** ******** ****** ****** ******** ******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
***** *** / ********* ***** **, **** ********* **** / ******* **** *** ****** *** ****
****** ** / ** *** **, **** ******* ***** ********* ************ **** ******* *** **** *** *** ****
  1. *** **, **** : * **** ** *** ***** *** ***** ** * *** *******.
  2. *** *, **** : ***** ******** ****** (****** ****** ** ******* '*** *** '***) ********* *** **** ** ****** *** * ******.
  3. *** **, **** : ****** **** ***** **** ******* '*** *** '*** **** ******** ** *** **, ****.
  4. *** **, **** : ****** **** ***** ( ******* **** ***- *** ****** ** *** *** *** **** *******) **** ******* '***, '***, '*** *** '***.
  5. *** **, **** : ****** ******** ****** ** *** ****-** ****** **** ******* '***, '***, '***, '***, '*** *** '***
  6. *** **, **** : ****** **** ****** **** ************ ** ******* '***, '***, '***, '***, *** '***. ****** ***** * ******** **** **** ******* '*** *** '***.
  7. *** *, **** : ****** ******** ********* ********* ***-** ******* '*** *** '*** ******* *****. ***** ****** ** ********** ******* ****** ** ****** '*** *** '***, *** **** ****** ****** ****** *** **, ****
  8. *** **, **** : ****** *** ****** ******* ****** ** ******* ********** ********* ****** '*** ******** ****** ****** *** ***** *** ********** *.*. ****** *** *** ****** '***. ** *** ****** '***, ****** ****** ** ************, *** *** ******** ********* ******* *******. ****** ******** ********* ********* ***-** ******* '***, '*** *** '***
  9. *** **, **** : ****** *** ***** ******* ********** **** ******* '*** *** '***. *** ********** ** ***** ******* ****** *******.
  10. *** *, **** : ****** ***** * *** **** ******* ***** *** *** (*** *** **-********** *** ***** ****) **** ************ ** ******* '*** *** '***. *** ********** ** *** ******** *****, *****'* ************ *********** ****** *** ****.
  11. *** **, **** : ****** *** ****** ******* ********** **** ********* ******* ** ******* *****.

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.   Privacy Policy.   Terms and Conditions.